Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis
Background: Bufalin, the main active ingredient of the traditional Chinese medicine huachansu, is used in the clinical treatment of colorectal cancer and has multiple effects, including the inhibition of migratory invasion, reversal of multi-drug resistance, induction of apoptosis and differentiatio...
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Elsevier
2024-01-01
|
| Col·lecció: | Heliyon |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2405844024004262 |